Zhang Z - Search Results

1

Development of a CAFs-related gene signature to predict survival and drug response in bladder cancer.

Zhang Z, Liang Z, Li D, Wang L, Chen Y, Liang Y, Jiao W, Niu H. Zhang Z, et al. Hum Cell. 2022 Mar;35(2):649-664. doi: 10.1007/s13577-022-00673-w. Epub 2022 Jan 19. Hum Cell. 2022. PMID: 35044630

2

Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer.

Zhang Z, Yu Y, Zhang P, Ma G, Zhang M, Liang Y, Jiao W, Niu H. Zhang Z, et al. Among authors: zhang m, zhang p. BMC Cancer. 2021 Apr 24;21(1):458. doi: 10.1186/s12885-021-08229-1. BMC Cancer. 2021. PMID: 33894748 Free PMC article.

3

Application of deterministic networking for reducing network delay in urological telesurgery: A retrospective study.

Zhang Z, Wang Y, Zhang Z, Zheng J, Su Z, Gui H, Jiao W, Yang X, Niu H. Zhang Z, et al. Int J Med Robot. 2022 Apr;18(2):e2365. doi: 10.1002/rcs.2365. Epub 2022 Jan 15. Int J Med Robot. 2022. PMID: 34996124

4

CYP27A1 inhibits proliferation and migration of clear cell renal cell carcinoma via activation of LXRs/ABCA1.

Liang Z, Jiao W, Wang L, Chen Y, Li D, Zhang Z, Zhang Z, Liang Y, Niu H. Liang Z, et al. Among authors: zhang z. Exp Cell Res. 2022 Oct 1;419(1):113279. doi: 10.1016/j.yexcr.2022.113279. Epub 2022 Jul 8. Exp Cell Res. 2022. PMID: 35810773

5

Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment.

Ma G, Zhang Z, Li P, Zhang Z, Zeng M, Liang Z, Li D, Wang L, Chen Y, Liang Y, Niu H. Ma G, et al. Among authors: zhang z. Cell Commun Signal. 2022 Jul 27;20(1):114. doi: 10.1186/s12964-022-00909-0. Cell Commun Signal. 2022. PMID: 35897036 Free PMC article. Review.

6

Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer.

Zhang Z, Yu Y, Li P, Wang M, Jiao W, Liang Y, Niu H. Zhang Z, et al. Front Immunol. 2022 Jul 25;13:954616. doi: 10.3389/fimmu.2022.954616. eCollection 2022. Front Immunol. 2022. PMID: 35958586 Free PMC article.

7

A Nano-Autophagy Inhibitor Triggering Reciprocal Feedback Control of Cholesterol Depletion for Solid Tumor Therapy.

Zhang P, Shi Y, Xu Y, Liang Y, Huang C, Zhong D, Zhang Z, Yu Y, Zhang Z, Zhang J, Yu L, Zuo Y, Wang X, Niu H. Zhang P, et al. Among authors: zhang z, zhang j. Adv Healthc Mater. 2023 Dec;12(32):e2302020. doi: 10.1002/adhm.202302020. Epub 2023 Oct 10. Adv Healthc Mater. 2023. PMID: 37767984

8

Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1.

Zhang Z, Yu Y, Zhang Z, Li D, Liang Z, Wang L, Chen Y, Liang Y, Niu H. Zhang Z, et al. J Exp Clin Cancer Res. 2023 Nov 25;42(1):316. doi: 10.1186/s13046-023-02900-0. J Exp Clin Cancer Res. 2023. PMID: 38001512 Free PMC article.

9

Bioinformatics Analysis to Screen the Key Prognostic Genes in Tumor Microenvironment of Bladder Cancer.

Zhang Z, Chen D, Li Z, Liu Z, Yan L, Xu Z. Zhang Z, et al. Biomed Res Int. 2020 Feb 17;2020:6034670. doi: 10.1155/2020/6034670. eCollection 2020. Biomed Res Int. 2020. PMID: 32149116 Free PMC article.

10

Construction and validation of a prognostic model of RNA binding proteins in clear cell renal carcinoma.

Han W, Fan B, Huang Y, Wang X, Zhang Z, Gu G, Liu Z. Han W, et al. Among authors: zhang z. BMC Nephrol. 2022 May 5;23(1):172. doi: 10.1186/s12882-022-02801-y. BMC Nephrol. 2022. PMID: 35513791 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111,502 results

Search Page

Filters